(Q33667584)

28 July 2017

1 reference

title

Postmastectomy radiation in patients with one to three positive axillary nodes receiving adjuvant chemotherapy: An unresolved issue (English)

1 reference

28 July 2017

1 reference

Fowble B

1

1 reference

28 July 2017

language of work or name

1 reference

1 July 1999

1 reference

Seminars in Radiation Oncology

28 July 2017

published in

1 reference

28 July 2017

volume

9

1 reference

28 July 2017

issue

3

1 reference

28 July 2017

page(s)

230-240

1 reference

Effects of radiotherapy and surgery in early breast cancer. An overview of the randomized trials

28 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1053-4296%2899%2980014-9

7 January 2021

Postoperative radiotherapy in breast cancer--long-term results from the Oslo study

1 reference

https://api.crossref.org/works/10.1016%2FS1053-4296%2899%2980014-9

7 January 2021

Ten-year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation

1 reference

https://api.crossref.org/works/10.1016%2FS1053-4296%2899%2980014-9

7 January 2021

Postoperative radiotherapy in the treatment of breast cancer: results of the NSABP clinical trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1053-4296%2899%2980014-9

7 January 2021

Cause-specific mortality in long-term survivors of breast cancer who participated in trials of radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1053-4296%2899%2980014-9

7 January 2021

Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group

1 reference

https://api.crossref.org/works/10.1016%2FS1053-4296%2899%2980014-9

7 January 2021

Postmastectomy radiotherapy: questions for the twenty-first century

1 reference

https://api.crossref.org/works/10.1016%2FS1053-4296%2899%2980014-9

7 January 2021

"One to three" or "four or more"?: selecting patients for postmastectomy radiation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1053-4296%2899%2980014-9

7 January 2021

Identification of a subgroup of patients with breast cancer and histologically positive axillary nodes receiving adjuvant chemotherapy who may benefit from postoperative radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1053-4296%2899%2980014-9

7 January 2021

Local-regional failure in patients treated with adjuvant chemotherapy for breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1053-4296%2899%2980014-9

7 January 2021

Patterns of tumor relapse following mastectomy and adjuvant systemic therapy in patients with axillary lymph node-positive breast cancer. Impact of clinical, histopathologic, and flow cytometric factors

1 reference

https://api.crossref.org/works/10.1016%2FS1053-4296%2899%2980014-9

7 January 2021

Adequate locoregional treatment for early breast cancer may prevent secondary dissemination

1 reference

https://api.crossref.org/works/10.1016%2FS1053-4296%2899%2980014-9

7 January 2021

Local-regional recurrence in breast cancer after mastectomy and adriamycin-based adjuvant chemotherapy: evaluation of the role of postoperative radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1053-4296%2899%2980014-9

7 January 2021

Adjuvant chemotherapy with doxorubicin plus cyclophosphamide, methotrexate, and fluorouracil in the treatment of resectable breast cancer with more than three positive axillary nodes

1 reference

https://api.crossref.org/works/10.1016%2FS1053-4296%2899%2980014-9

7 January 2021

Radiation therapy and survival in breast cancer patients with 10 or more positive axillary lymph nodes treated with mastectomy

1 reference

https://api.crossref.org/works/10.1016%2FS1053-4296%2899%2980014-9

7 January 2021

The impact of conventional plus high dose chemotherapy with autologous bone marrow transplantation on hematologic toxicity during subsequent local-regional radiotherapy for breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1053-4296%2899%2980014-9

7 January 2021

Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1053-4296%2899%2980014-9

7 January 2021

Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1053-4296%2899%2980014-9

7 January 2021

The return (?) of postmastectomy radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1053-4296%2899%2980014-9

7 January 2021

Locoregional failure rates in patients with involved axillary nodes after mastectomy and systemic therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1053-4296%2899%2980014-9

7 January 2021

The results of radiation therapy for isolated local regional recurrence after mastectomy

1 reference

https://api.crossref.org/works/10.1016%2FS1053-4296%2899%2980014-9

7 January 2021

Isolated local-regional recurrence of breast cancer following mastectomy: radiotherapeutic management

1 reference

https://api.crossref.org/works/10.1016%2FS1053-4296%2899%2980014-9

7 January 2021

Adjuvant radiation therapy versus surgery alone in operable breast cancer: long-term follow-up of a randomized clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS1053-4296%2899%2980014-9

7 January 2021

A randomized trial of chemotherapy (L-PAM vs CMF) and irradiation for node positive breast cancer. Eleven year follow-up of a Piedmont Oncology Association trial

1 reference

https://api.crossref.org/works/10.1016%2FS1053-4296%2899%2980014-9

7 January 2021

Adjuvant radiotherapy and chemotherapy in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1053-4296%2899%2980014-9

7 January 2021

Adjuvant randomized trials of doxorubicin/cyclophosphamide versus doxorubicin/cyclophosphamide/tamoxifen and CMF chemotherapy versus tamoxifen in women with node-positive breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1053-4296%2899%2980014-9

7 January 2021

A close or positive margin after mastectomy is not an indication for chest wall irradiation except in women aged fifty or younger

1 reference

https://api.crossref.org/works/10.1016%2FS1053-4296%2899%2980014-9

7 January 2021

Prognostic significance of axillary nodal status in primary breast cancer in relation to the number of resected nodes. Stockholm Breast Cancer Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1053-4296%2899%2980014-9

7 January 2021

Long-term follow-up of axillary node-positive breast cancer patients receiving adjuvant systemic therapy alone: patterns of recurrence

1 reference

https://api.crossref.org/works/10.1016%2FS1053-4296%2899%2980014-9

7 January 2021

Simple mastectomy and axillary node sampling (pectoral node biopsy) in the management of primary breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1053-4296%2899%2980014-9

7 January 2021

A Comparison of Modified Radical Mastectomy to Radical Mastectomy in the Treatment of Operable Breast Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1053-4296%2899%2980014-9

7 January 2021

A randomized prospective trial of radical (Halsted) mastectomy versus modified radical mastectomy in 311 breast cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS1053-4296%2899%2980014-9

7 January 2021

Cyclophosphamide, methotrexate, and fluorouracil with and without doxorubicin in the adjuvant treatment of resectable breast cancer with one to three positive axillary nodes

1 reference

https://api.crossref.org/works/10.1016%2FS1053-4296%2899%2980014-9

7 January 2021

Dose and dose intensity of adjuvant chemotherapy for stage II, node-positive breast carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1053-4296%2899%2980014-9

7 January 2021

Increased intensification and total dose of cyclophosphamide in a doxorubicin-cyclophosphamide regimen for the treatment of primary breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-22

1 reference

https://api.crossref.org/works/10.1016%2FS1053-4296%2899%2980014-9

7 January 2021

The 5-year results of a randomized trial of adjuvant radiation therapy after chemotherapy in breast cancer patients treated with mastectomy.

1 reference

https://api.crossref.org/works/10.1016%2FS1053-4296%2899%2980014-9

7 January 2021

Evaluation of radiotherapy in high-risk breast cancer patients: report from the Danish Breast Cancer Cooperative Group (DBCG 82) Trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1053-4296%2899%2980014-9

7 January 2021

A mathematical model of axillary lymph node involvement based on 1446 complete axillary dissections in patients with breast carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1053-4296%2899%2980014-9

7 January 2021

The sentinel node in breast cancer--a multicenter validation study

1 reference

https://api.crossref.org/works/10.1016%2FS1053-4296%2899%2980014-9

7 January 2021

Stopping metastases at their source

1 reference

https://api.crossref.org/works/10.1016%2FS1053-4296%2899%2980014-9

7 January 2021

Results of irradiation in the treatment of locoregional breast cancer recurrence

1 reference

https://api.crossref.org/works/10.1016%2FS1053-4296%2899%2980014-9

7 January 2021

Analysis of prognostic factors in patients with isolated chest wall recurrence of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1053-4296%2899%2980014-9

7 January 2021

Risk of internal mammary lymph node metastases and its relevance on prognosis of breast cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS1053-4296%2899%2980014-9

7 January 2021

Effect of preoperative chemotherapy on the outcome of women with operable breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1053-4296%2899%2980014-9

7 January 2021

Adjuvant chemotherapy with fluorouracil, doxorubicin, and cyclophosphamide, with or without Bacillus Calmette-Guerin and with or without irradiation in operable breast cancer a prospective randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS1053-4296%2899%2980014-9

7 January 2021

10.1016/S1053-4296(99)80014-9

Identifiers

DOI

1 reference

28 July 2017

1 reference